Award recordCONTRACT

ALBA BIOSCIENCE, INC.

PIID 36C25924N0257· VHA· NETWORK CONTRACT OFFICE 19 (36C259)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2024· $20,527 net obligations· UEI V6KNKL6BDHL7· IL

Description

QUOTIENTBD BLOOD BANK TRANSFUSION REAGENTS

First action · last action
2024-05-07 · 2025-12-23
Transactions
3
First transaction's obligation
$54,925
Base + all options value (sum of deltas)
$20,527
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25923A0014
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$54,925$0Base award · 2024-05-07 · this action $54,925 · running total $54,925Modification P00001 · 2025-10-29 · this action -$7,655 · running total $47,271Modification P00002 · 2025-12-23 · this action -$26,744 · running total $20,527
  • Base2024-05-07+$54,925= $54,925
  • Mod P000012025-10-29-$7,655= $47,271
  • Mod P000022025-12-23-$26,744= $20,527
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-05-07+$54,925$54,925QUOTIENTBD BLOOD BANK TRANSFUSION REAGENTS
Mod P00001· FUNDING ONLY ACTION2025-10-29−$7,655$47,271QUOTIENTBD BLOOD BANK TRANSFUSION REAGENTS
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-12-23−$26,744$20,527QUOTIENTBD BLOOD BANK TRANSFUSION REAGENTS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI V6KNKL6BDHL7)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0306255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$40,949FY2026
36C25926N0280NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$64,078FY2026
36C25726N0176257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$7,634FY2026
36C25726N0224257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$16,514FY2026
36C25626N0214256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$23,127FY2026
36C25026N0043250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$21,884FY2026

Other recipients under 6550 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25926N0457BECTON, DICKINSON AND COMPANYNETWORK CONTRACT OFFICE 19 (36C259)$147,256FY2026
36C25926N0353QIAGEN, LLCNETWORK CONTRACT OFFICE 19 (36C259)$88,310FY2026
36C25926N0292FISHER SCIENTIFIC COMPANY L.L.C.NETWORK CONTRACT OFFICE 19 (36C259)$165,000FY2026
36C25926N0316POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLCNETWORK CONTRACT OFFICE 19 (36C259)$50,343FY2026
36C25926N0324BIOFIRE DIAGNOSTICS LLCNETWORK CONTRACT OFFICE 19 (36C259)$186,386FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25924N0257_3600_36C25923A0014_3600 · retrieved 2026-09-26.